MedPath
HSA Approval

DIPRODIN ELIXIR

SIN07830P

DIPRODIN ELIXIR

DIPRODIN ELIXIR

September 1, 1994

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R05FB02

cough suppressants and expectorants

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

EPHEDRINE HCL

6 mg/5 ml

Ephedrine

DIPHENHYDRAMINE HCl

12.5 mg/5 ml

Diphenhydramine

DIPHENHYDRAMINE HCL

12.5 mg/5 ml

Diphenhydramine

EPHEDRINE HCl

6 mg/5 ml

Ephedrine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIPRODIN ELIXIR - HSA Approval | MedPath